Table of Content

1 Anti-Viral Cold And Flu Granule Market Overview
1.1 Anti-Viral Cold And Flu Granule Product Overview
1.2 Anti-Viral Cold And Flu Granule Market Segment by Type
1.2.1 Children's Edition
1.2.2 Adults' Edition
1.3 Global Anti-Viral Cold And Flu Granule Market Size by Type
1.3.1 Global Anti-Viral Cold And Flu Granule Market Size Overview by Type (2024-2034)
1.3.2 Global Anti-Viral Cold And Flu Granule Historic Market Size Review by Type (2024-2024)
1.3.3 Global Anti-Viral Cold And Flu Granule Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Anti-Viral Cold And Flu Granule Sales Breakdown by Type (2024-2024)
1.4.2 Europe Anti-Viral Cold And Flu Granule Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Anti-Viral Cold And Flu Granule Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Anti-Viral Cold And Flu Granule Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Anti-Viral Cold And Flu Granule Sales Breakdown by Type (2024-2024)
2 Global Anti-Viral Cold And Flu Granule Market Competition by Company
2.1 Global Top Players by Anti-Viral Cold And Flu Granule Sales (2024-2024)
2.2 Global Top Players by Anti-Viral Cold And Flu Granule Revenue (2024-2024)
2.3 Global Top Players by Anti-Viral Cold And Flu Granule Price (2024-2024)
2.4 Global Top Manufacturers Anti-Viral Cold And Flu Granule Manufacturing Base Distribution, Sales Area, Product Type
2.5 Anti-Viral Cold And Flu Granule Market Competitive Situation and Trends
2.5.1 Anti-Viral Cold And Flu Granule Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Anti-Viral Cold And Flu Granule Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anti-Viral Cold And Flu Granule as of 2022)
2.7 Date of Key Manufacturers Enter into Anti-Viral Cold And Flu Granule Market
2.8 Key Manufacturers Anti-Viral Cold And Flu Granule Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Anti-Viral Cold And Flu Granule Status and Outlook by Region
3.1 Global Anti-Viral Cold And Flu Granule Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Anti-Viral Cold And Flu Granule Historic Market Size by Region
3.2.1 Global Anti-Viral Cold And Flu Granule Sales in Volume by Region (2024-2024)
3.2.2 Global Anti-Viral Cold And Flu Granule Sales in Value by Region (2024-2024)
3.2.3 Global Anti-Viral Cold And Flu Granule Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Anti-Viral Cold And Flu Granule Forecasted Market Size by Region
3.3.1 Global Anti-Viral Cold And Flu Granule Sales in Volume by Region (2024-2034)
3.3.2 Global Anti-Viral Cold And Flu Granule Sales in Value by Region (2024-2034)
3.3.3 Global Anti-Viral Cold And Flu Granule Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Anti-Viral Cold And Flu Granule by Application
4.1 Anti-Viral Cold And Flu Granule Market Segment by Application
4.1.1 Retail Pharmacies
4.1.2 Hospital
4.1.3 Online Sales Platforms
4.2 Global Anti-Viral Cold And Flu Granule Market Size by Application
4.2.1 Global Anti-Viral Cold And Flu Granule Market Size Overview by Application (2024-2034)
4.2.2 Global Anti-Viral Cold And Flu Granule Historic Market Size Review by Application (2024-2024)
4.2.3 Global Anti-Viral Cold And Flu Granule Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Anti-Viral Cold And Flu Granule Sales Breakdown by Application (2024-2024)
4.3.2 Europe Anti-Viral Cold And Flu Granule Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Anti-Viral Cold And Flu Granule Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Anti-Viral Cold And Flu Granule Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Anti-Viral Cold And Flu Granule Sales Breakdown by Application (2024-2024)
5 North America Anti-Viral Cold And Flu Granule by Country
5.1 North America Anti-Viral Cold And Flu Granule Historic Market Size by Country
5.1.1 North America Anti-Viral Cold And Flu Granule Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Anti-Viral Cold And Flu Granule Sales in Volume by Country (2024-2024)
5.1.3 North America Anti-Viral Cold And Flu Granule Sales in Value by Country (2024-2024)
5.2 North America Anti-Viral Cold And Flu Granule Forecasted Market Size by Country
5.2.1 North America Anti-Viral Cold And Flu Granule Sales in Volume by Country (2024-2034)
5.2.2 North America Anti-Viral Cold And Flu Granule Sales in Value by Country (2024-2034)
6 Europe Anti-Viral Cold And Flu Granule by Country
6.1 Europe Anti-Viral Cold And Flu Granule Historic Market Size by Country
6.1.1 Europe Anti-Viral Cold And Flu Granule Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Anti-Viral Cold And Flu Granule Sales in Volume by Country (2024-2024)
6.1.3 Europe Anti-Viral Cold And Flu Granule Sales in Value by Country (2024-2024)
6.2 Europe Anti-Viral Cold And Flu Granule Forecasted Market Size by Country
6.2.1 Europe Anti-Viral Cold And Flu Granule Sales in Volume by Country (2024-2034)
6.2.2 Europe Anti-Viral Cold And Flu Granule Sales in Value by Country (2024-2034)
7 Asia-Pacific Anti-Viral Cold And Flu Granule by Region
7.1 Asia-Pacific Anti-Viral Cold And Flu Granule Historic Market Size by Region
7.1.1 Asia-Pacific Anti-Viral Cold And Flu Granule Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Anti-Viral Cold And Flu Granule Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Anti-Viral Cold And Flu Granule Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Anti-Viral Cold And Flu Granule Forecasted Market Size by Region
7.2.1 Asia-Pacific Anti-Viral Cold And Flu Granule Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Anti-Viral Cold And Flu Granule Sales in Value by Region (2024-2034)
8 Latin America Anti-Viral Cold And Flu Granule by Country
8.1 Latin America Anti-Viral Cold And Flu Granule Historic Market Size by Country
8.1.1 Latin America Anti-Viral Cold And Flu Granule Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Anti-Viral Cold And Flu Granule Sales in Volume by Country (2024-2024)
8.1.3 Latin America Anti-Viral Cold And Flu Granule Sales in Value by Country (2024-2024)
8.2 Latin America Anti-Viral Cold And Flu Granule Forecasted Market Size by Country
8.2.1 Latin America Anti-Viral Cold And Flu Granule Sales in Volume by Country (2024-2034)
8.2.2 Latin America Anti-Viral Cold And Flu Granule Sales in Value by Country (2024-2034)
9 Middle East and Africa Anti-Viral Cold And Flu Granule by Country
9.1 Middle East and Africa Anti-Viral Cold And Flu Granule Historic Market Size by Country
9.1.1 Middle East and Africa Anti-Viral Cold And Flu Granule Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Anti-Viral Cold And Flu Granule Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Anti-Viral Cold And Flu Granule Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Anti-Viral Cold And Flu Granule Forecasted Market Size by Country
9.2.1 Middle East and Africa Anti-Viral Cold And Flu Granule Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Anti-Viral Cold And Flu Granule Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 WELEDA
10.1.1 WELEDA Company Information
10.1.2 WELEDA Introduction and Business Overview
10.1.3 WELEDA Anti-Viral Cold And Flu Granule Sales, Revenue and Gross Margin (2024-2024)
10.1.4 WELEDA Anti-Viral Cold And Flu Granule Products Offered
10.1.5 WELEDA Recent Development
10.2 Sichuan Everbright Pharmaceutical
10.2.1 Sichuan Everbright Pharmaceutical Company Information
10.2.2 Sichuan Everbright Pharmaceutical Introduction and Business Overview
10.2.3 Sichuan Everbright Pharmaceutical Anti-Viral Cold And Flu Granule Sales, Revenue and Gross Margin (2024-2024)
10.2.4 Sichuan Everbright Pharmaceutical Anti-Viral Cold And Flu Granule Products Offered
10.2.5 Sichuan Everbright Pharmaceutical Recent Development
10.3 Shandong Wohua Pharmaceutical
10.3.1 Shandong Wohua Pharmaceutical Company Information
10.3.2 Shandong Wohua Pharmaceutical Introduction and Business Overview
10.3.3 Shandong Wohua Pharmaceutical Anti-Viral Cold And Flu Granule Sales, Revenue and Gross Margin (2024-2024)
10.3.4 Shandong Wohua Pharmaceutical Anti-Viral Cold And Flu Granule Products Offered
10.3.5 Shandong Wohua Pharmaceutical Recent Development
10.4 Liaoning Xingao Pharmaceutical
10.4.1 Liaoning Xingao Pharmaceutical Company Information
10.4.2 Liaoning Xingao Pharmaceutical Introduction and Business Overview
10.4.3 Liaoning Xingao Pharmaceutical Anti-Viral Cold And Flu Granule Sales, Revenue and Gross Margin (2024-2024)
10.4.4 Liaoning Xingao Pharmaceutical Anti-Viral Cold And Flu Granule Products Offered
10.4.5 Liaoning Xingao Pharmaceutical Recent Development
10.5 Hubei Longda Medicine Technology
10.5.1 Hubei Longda Medicine Technology Company Information
10.5.2 Hubei Longda Medicine Technology Introduction and Business Overview
10.5.3 Hubei Longda Medicine Technology Anti-Viral Cold And Flu Granule Sales, Revenue and Gross Margin (2024-2024)
10.5.4 Hubei Longda Medicine Technology Anti-Viral Cold And Flu Granule Products Offered
10.5.5 Hubei Longda Medicine Technology Recent Development
10.6 Guangzhou Huacheng pharmaceutical plant
10.6.1 Guangzhou Huacheng pharmaceutical plant Company Information
10.6.2 Guangzhou Huacheng pharmaceutical plant Introduction and Business Overview
10.6.3 Guangzhou Huacheng pharmaceutical plant Anti-Viral Cold And Flu Granule Sales, Revenue and Gross Margin (2024-2024)
10.6.4 Guangzhou Huacheng pharmaceutical plant Anti-Viral Cold And Flu Granule Products Offered
10.6.5 Guangzhou Huacheng pharmaceutical plant Recent Development
10.7 Confidence
10.7.1 Confidence Company Information
10.7.2 Confidence Introduction and Business Overview
10.7.3 Confidence Anti-Viral Cold And Flu Granule Sales, Revenue and Gross Margin (2024-2024)
10.7.4 Confidence Anti-Viral Cold And Flu Granule Products Offered
10.7.5 Confidence Recent Development
10.8 Zhuhai AIA Pharmaceutical
10.8.1 Zhuhai AIA Pharmaceutical Company Information
10.8.2 Zhuhai AIA Pharmaceutical Introduction and Business Overview
10.8.3 Zhuhai AIA Pharmaceutical Anti-Viral Cold And Flu Granule Sales, Revenue and Gross Margin (2024-2024)
10.8.4 Zhuhai AIA Pharmaceutical Anti-Viral Cold And Flu Granule Products Offered
10.8.5 Zhuhai AIA Pharmaceutical Recent Development
10.9 Taihua Pharmacy
10.9.1 Taihua Pharmacy Company Information
10.9.2 Taihua Pharmacy Introduction and Business Overview
10.9.3 Taihua Pharmacy Anti-Viral Cold And Flu Granule Sales, Revenue and Gross Margin (2024-2024)
10.9.4 Taihua Pharmacy Anti-Viral Cold And Flu Granule Products Offered
10.9.5 Taihua Pharmacy Recent Development
10.10 Jiangsu Jurong Pharmaceutical
10.10.1 Jiangsu Jurong Pharmaceutical Company Information
10.10.2 Jiangsu Jurong Pharmaceutical Introduction and Business Overview
10.10.3 Jiangsu Jurong Pharmaceutical Anti-Viral Cold And Flu Granule Sales, Revenue and Gross Margin (2024-2024)
10.10.4 Jiangsu Jurong Pharmaceutical Anti-Viral Cold And Flu Granule Products Offered
10.10.5 Jiangsu Jurong Pharmaceutical Recent Development
10.11 Jiangsu Kanion Pharmaceutical
10.11.1 Jiangsu Kanion Pharmaceutical Company Information
10.11.2 Jiangsu Kanion Pharmaceutical Introduction and Business Overview
10.11.3 Jiangsu Kanion Pharmaceutical Anti-Viral Cold And Flu Granule Sales, Revenue and Gross Margin (2024-2024)
10.11.4 Jiangsu Kanion Pharmaceutical Anti-Viral Cold And Flu Granule Products Offered
10.11.5 Jiangsu Kanion Pharmaceutical Recent Development
10.12 Laotongjun Pharmaceutical
10.12.1 Laotongjun Pharmaceutical Company Information
10.12.2 Laotongjun Pharmaceutical Introduction and Business Overview
10.12.3 Laotongjun Pharmaceutical Anti-Viral Cold And Flu Granule Sales, Revenue and Gross Margin (2024-2024)
10.12.4 Laotongjun Pharmaceutical Anti-Viral Cold And Flu Granule Products Offered
10.12.5 Laotongjun Pharmaceutical Recent Development
10.13 Wuhan Jinpu Pharmaceutical
10.13.1 Wuhan Jinpu Pharmaceutical Company Information
10.13.2 Wuhan Jinpu Pharmaceutical Introduction and Business Overview
10.13.3 Wuhan Jinpu Pharmaceutical Anti-Viral Cold And Flu Granule Sales, Revenue and Gross Margin (2024-2024)
10.13.4 Wuhan Jinpu Pharmaceutical Anti-Viral Cold And Flu Granule Products Offered
10.13.5 Wuhan Jinpu Pharmaceutical Recent Development
10.14 Jiangsu Xinxian Pharmaceutical
10.14.1 Jiangsu Xinxian Pharmaceutical Company Information
10.14.2 Jiangsu Xinxian Pharmaceutical Introduction and Business Overview
10.14.3 Jiangsu Xinxian Pharmaceutical Anti-Viral Cold And Flu Granule Sales, Revenue and Gross Margin (2024-2024)
10.14.4 Jiangsu Xinxian Pharmaceutical Anti-Viral Cold And Flu Granule Products Offered
10.14.5 Jiangsu Xinxian Pharmaceutical Recent Development
10.15 Quetzal
10.15.1 Quetzal Company Information
10.15.2 Quetzal Introduction and Business Overview
10.15.3 Quetzal Anti-Viral Cold And Flu Granule Sales, Revenue and Gross Margin (2024-2024)
10.15.4 Quetzal Anti-Viral Cold And Flu Granule Products Offered
10.15.5 Quetzal Recent Development
10.16 Kangxin Pharmaceutical
10.16.1 Kangxin Pharmaceutical Company Information
10.16.2 Kangxin Pharmaceutical Introduction and Business Overview
10.16.3 Kangxin Pharmaceutical Anti-Viral Cold And Flu Granule Sales, Revenue and Gross Margin (2024-2024)
10.16.4 Kangxin Pharmaceutical Anti-Viral Cold And Flu Granule Products Offered
10.16.5 Kangxin Pharmaceutical Recent Development
10.17 SHANXI TAIHANG PHARMACEUTICAL
10.17.1 SHANXI TAIHANG PHARMACEUTICAL Company Information
10.17.2 SHANXI TAIHANG PHARMACEUTICAL Introduction and Business Overview
10.17.3 SHANXI TAIHANG PHARMACEUTICAL Anti-Viral Cold And Flu Granule Sales, Revenue and Gross Margin (2024-2024)
10.17.4 SHANXI TAIHANG PHARMACEUTICAL Anti-Viral Cold And Flu Granule Products Offered
10.17.5 SHANXI TAIHANG PHARMACEUTICAL Recent Development
10.18 Henan Tongyuan Pharmaceutical
10.18.1 Henan Tongyuan Pharmaceutical Company Information
10.18.2 Henan Tongyuan Pharmaceutical Introduction and Business Overview
10.18.3 Henan Tongyuan Pharmaceutical Anti-Viral Cold And Flu Granule Sales, Revenue and Gross Margin (2024-2024)
10.18.4 Henan Tongyuan Pharmaceutical Anti-Viral Cold And Flu Granule Products Offered
10.18.5 Henan Tongyuan Pharmaceutical Recent Development
10.19 BAIHUI PHARMA
10.19.1 BAIHUI PHARMA Company Information
10.19.2 BAIHUI PHARMA Introduction and Business Overview
10.19.3 BAIHUI PHARMA Anti-Viral Cold And Flu Granule Sales, Revenue and Gross Margin (2024-2024)
10.19.4 BAIHUI PHARMA Anti-Viral Cold And Flu Granule Products Offered
10.19.5 BAIHUI PHARMA Recent Development
10.20 Xiangxue Pharmaceutical
10.20.1 Xiangxue Pharmaceutical Company Information
10.20.2 Xiangxue Pharmaceutical Introduction and Business Overview
10.20.3 Xiangxue Pharmaceutical Anti-Viral Cold And Flu Granule Sales, Revenue and Gross Margin (2024-2024)
10.20.4 Xiangxue Pharmaceutical Anti-Viral Cold And Flu Granule Products Offered
10.20.5 Xiangxue Pharmaceutical Recent Development
10.21 North Hulunbuir pharmaceutical limited company
10.21.1 North Hulunbuir pharmaceutical limited company Company Information
10.21.2 North Hulunbuir pharmaceutical limited company Introduction and Business Overview
10.21.3 North Hulunbuir pharmaceutical limited company Anti-Viral Cold And Flu Granule Sales, Revenue and Gross Margin (2024-2024)
10.21.4 North Hulunbuir pharmaceutical limited company Anti-Viral Cold And Flu Granule Products Offered
10.21.5 North Hulunbuir pharmaceutical limited company Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Anti-Viral Cold And Flu Granule Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Anti-Viral Cold And Flu Granule Industrial Chain Analysis
11.4 Anti-Viral Cold And Flu Granule Market Dynamics
11.4.1 Anti-Viral Cold And Flu Granule Industry Trends
11.4.2 Anti-Viral Cold And Flu Granule Market Drivers
11.4.3 Anti-Viral Cold And Flu Granule Market Challenges
11.4.4 Anti-Viral Cold And Flu Granule Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Anti-Viral Cold And Flu Granule Distributors
12.3 Anti-Viral Cold And Flu Granule Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Children's Edition
Table 2. Major Company of Adults' Edition
Table 3. Global Anti-Viral Cold And Flu Granule Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 4. Global Anti-Viral Cold And Flu Granule Sales by Type (2024-2024) & (K Units)
Table 5. Global Anti-Viral Cold And Flu Granule Sales Market Share in Volume by Type (2024-2024)
Table 6. Global Anti-Viral Cold And Flu Granule Sales by Type (2024-2024) & (US& Million)
Table 7. Global Anti-Viral Cold And Flu Granule Market Share in Value by Type (2024-2024)
Table 8. Global Anti-Viral Cold And Flu Granule Price by Type (2024-2024) & (US$/Unit)
Table 9. Global Anti-Viral Cold And Flu Granule Sales by Type (2024-2034) & (K Units)
Table 10. Global Anti-Viral Cold And Flu Granule Sales Market Share in Volume by Type (2024-2034)
Table 11. Global Anti-Viral Cold And Flu Granule Sales by Type (2024-2034) & (US$ Million)
Table 12. Global Anti-Viral Cold And Flu Granule Sales Market Share in Value by Type (2024-2034)
Table 13. Global Anti-Viral Cold And Flu Granule Price by Type (2024-2034) & (US$/Unit)
Table 14. North America Anti-Viral Cold And Flu Granule Sales by Type (2024-2024) & (K Units)
Table 15. North America Anti-Viral Cold And Flu Granule Sales by Type (2024-2024) & (US$ Million)
Table 16. Europe Anti-Viral Cold And Flu Granule Sales (K Units) by Type (2024-2024)
Table 17. Europe Anti-Viral Cold And Flu Granule Sales by Type (2024-2024) & (US$ Million)
Table 18. Asia-Pacific Anti-Viral Cold And Flu Granule Sales (K Units) by Type (2024-2024)
Table 19. Asia-Pacific Anti-Viral Cold And Flu Granule Sales by Type (2024-2024) & (US$ Million)
Table 20. Latin America Anti-Viral Cold And Flu Granule Sales (K Units) by Type (2024-2024)
Table 21. Latin America Anti-Viral Cold And Flu Granule Sales by Type (2024-2024) & (US$ Million)
Table 22. Middle East and Africa Anti-Viral Cold And Flu Granule Sales (K Units) by Type (2024-2024)
Table 23. Middle East and Africa Anti-Viral Cold And Flu Granule Sales by Type (2024-2024) & (US$ Million)
Table 24. Global Anti-Viral Cold And Flu Granule Sales by Company (2024-2024) & (K Units)
Table 25. Global Anti-Viral Cold And Flu Granule Sales Share by Company (2024-2024)
Table 26. Global Anti-Viral Cold And Flu Granule Revenue by Company (2024-2024) & (US$ Million)
Table 27. Global Anti-Viral Cold And Flu Granule Revenue Share by Company (2024-2024)
Table 28. Global Market Anti-Viral Cold And Flu Granule Price by Company (2024-2024) & (US$/Unit)
Table 29. Global Anti-Viral Cold And Flu Granule Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Anti-Viral Cold And Flu Granule Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anti-Viral Cold And Flu Granule as of 2022)
Table 32. Date of Key Manufacturers Enter into Anti-Viral Cold And Flu Granule Market
Table 33. Key Manufacturers Anti-Viral Cold And Flu Granule Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Anti-Viral Cold And Flu Granule Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 36. Global Anti-Viral Cold And Flu Granule Sales by Region (2024-2024) & (K Units)
Table 37. Global Anti-Viral Cold And Flu Granule Sales Market Share in Volume by Region (2024-2024)
Table 38. Global Anti-Viral Cold And Flu Granule Sales by Region (2024-2024) & (US$ Million)
Table 39. Global Anti-Viral Cold And Flu Granule Sales Market Share in Value by Region (2024-2024)
Table 40. Global Anti-Viral Cold And Flu Granule Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 41. Global Anti-Viral Cold And Flu Granule Sales by Region (2024-2034) & (K Units)
Table 42. Global Anti-Viral Cold And Flu Granule Sales Market Share in Volume by Region (2024-2034)
Table 43. Global Anti-Viral Cold And Flu Granule Sales by Region (2024-2034) & (US$ Million)
Table 44. Global Anti-Viral Cold And Flu Granule Sales Market Share in Value by Region (2024-2034)
Table 45. Global Anti-Viral Cold And Flu Granule Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2034)
Table 46. Global Anti-Viral Cold And Flu Granule Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 47. Global Anti-Viral Cold And Flu Granule Sales by Application (2024-2024) & (K Units)
Table 48. Global Anti-Viral Cold And Flu Granule Sales Market Share in Volume by Application (2024-2024)
Table 49. Global Anti-Viral Cold And Flu Granule Sales by Application (2024-2024) & (US$ Million)
Table 50. Global Anti-Viral Cold And Flu Granule Sales Market Share in Value by Application (2024-2024)
Table 51. Global Anti-Viral Cold And Flu Granule Price by Application (2024-2024) & (US$/Unit)
Table 52. Global Anti-Viral Cold And Flu Granule Sales by Application (2024-2034) & (K Units)
Table 53. Global Anti-Viral Cold And Flu Granule Sales Market Share in Volume by Application (2024-2034)
Table 54. Global Anti-Viral Cold And Flu Granule Sales by Application (2024-2034) & (US$ Million)
Table 55. Global Anti-Viral Cold And Flu Granule Sales Market Share in Value by Application (2024-2034)
Table 56. Global Anti-Viral Cold And Flu Granule Price by Application (2024-2034) & (US$/Unit)
Table 57. North America Anti-Viral Cold And Flu Granule Sales by Application (2024-2024) (K Units)
Table 58. North America Anti-Viral Cold And Flu Granule Sales by Application (2024-2024) & (US$ Million)
Table 59. Europe Anti-Viral Cold And Flu Granule Sales by Application (2024-2024) (K Units)
Table 60. Europe Anti-Viral Cold And Flu Granule Sales by Application (2024-2024) & (US$ Million)
Table 61. Asia-Pacific Anti-Viral Cold And Flu Granule Sales by Application (2024-2024) (K Units)
Table 62. Asia-Pacific Anti-Viral Cold And Flu Granule Sales by Application (2024-2024) & (US$ Million)
Table 63. Latin America Anti-Viral Cold And Flu Granule Sales by Application (2024-2024) (K Units)
Table 64. Latin America Anti-Viral Cold And Flu Granule Sales by Application (2024-2024) & (US$ Million)
Table 65. Middle East and Africa Anti-Viral Cold And Flu Granule Sales by Application (2024-2024) (K Units)
Table 66. Middle East and Africa Anti-Viral Cold And Flu Granule Sales by Application (2024-2024) & (US$ Million)
Table 67. North America Anti-Viral Cold And Flu Granule Sales by Country (2024-2024) & (K Units)
Table 68. North America Anti-Viral Cold And Flu Granule Sales Market Share in Volume by Country (2024-2024)
Table 69. North America Anti-Viral Cold And Flu Granule Sales by Country (2024-2024) & (US$ Million)
Table 70. North America Anti-Viral Cold And Flu Granule Sales Market Share in Value by Country (2024-2024)
Table 71. North America Anti-Viral Cold And Flu Granule Sales by Country (2024-2034) & (K Units)
Table 72. North America Anti-Viral Cold And Flu Granule Sales Market Share in Volume by Country (2024-2034)
Table 73. North America Anti-Viral Cold And Flu Granule Sales by Country (2024-2034) & (US$ Million)
Table 74. North America Anti-Viral Cold And Flu Granule Sales Market Share in Value by Country (2024-2034)
Table 75. Europe Anti-Viral Cold And Flu Granule Sales by Country (2024-2024) & (K Units)
Table 76. Europe Anti-Viral Cold And Flu Granule Sales Market Share in Volume by Country (2024-2024)
Table 77. Europe Anti-Viral Cold And Flu Granule Sales by Country (2024-2024) & (US$ Million)
Table 78. Europe Anti-Viral Cold And Flu Granule Sales Market Share in Value by Country (2024-2024)
Table 79. Europe Anti-Viral Cold And Flu Granule Sales by Country (2024-2034) & (K Units)
Table 80. Europe Anti-Viral Cold And Flu Granule Sales Market Share in Volume by Country (2024-2034)
Table 81. Europe Anti-Viral Cold And Flu Granule Sales by Country (2024-2034) & (US$ Million)
Table 82. Europe Anti-Viral Cold And Flu Granule Sales Market Share in Value by Country (2024-2034)
Table 83. Asia-Pacific Anti-Viral Cold And Flu Granule Sales by Region (2024-2024) & (K Units)
Table 84. Asia-Pacific Anti-Viral Cold And Flu Granule Sales Market Share in Volume by Region (2024-2024)
Table 85. Asia-Pacific Anti-Viral Cold And Flu Granule Sales by Region (2024-2024) & (US$ Million)
Table 86. Asia-Pacific Anti-Viral Cold And Flu Granule Sales Market Share in Value by Region (2024-2024)
Table 87. Asia-Pacific Anti-Viral Cold And Flu Granule Sales by Region (2024-2034) & (K Units)
Table 88. Asia-Pacific Anti-Viral Cold And Flu Granule Sales Market Share in Volume by Region (2024-2034)
Table 89. Asia-Pacific Anti-Viral Cold And Flu Granule Sales by Region (2024-2034) & (US$ Million)
Table 90. Asia-Pacific Anti-Viral Cold And Flu Granule Sales Market Share in Value by Region (2024-2034)
Table 91. Latin America Anti-Viral Cold And Flu Granule Sales by Country (2024-2024) & (K Units)
Table 92. Latin America Anti-Viral Cold And Flu Granule Sales Market Share in Volume by Country (2024-2024)
Table 93. Latin America Anti-Viral Cold And Flu Granule Sales by Country (2024-2024) & (US$ Million)
Table 94. Latin America Anti-Viral Cold And Flu Granule Sales Market Share in Value by Country (2024-2024)
Table 95. Latin America Anti-Viral Cold And Flu Granule Sales by Country (2024-2034) & (K Units)
Table 96. Latin America Anti-Viral Cold And Flu Granule Sales Market Share in Volume by Country (2024-2034)
Table 97. Latin America Anti-Viral Cold And Flu Granule Sales by Country (2024-2034) & (US$ Million)
Table 98. Latin America Anti-Viral Cold And Flu Granule Sales Market Share in Value by Country (2024-2034)
Table 99. Middle East and Africa Anti-Viral Cold And Flu Granule Sales by Country (2024-2024) & (K Units)
Table 100. Middle East and Africa Anti-Viral Cold And Flu Granule Sales Market Share in Volume by Country (2024-2024)
Table 101. Middle East and Africa Anti-Viral Cold And Flu Granule Sales by Country (2024-2024) & (US$ Million)
Table 102. Middle East and Africa Anti-Viral Cold And Flu Granule Sales Market Share in Value by Country (2024-2024)
Table 103. Middle East and Africa Anti-Viral Cold And Flu Granule Sales by Country (2024-2034) & (K Units)
Table 104. Middle East and Africa Anti-Viral Cold And Flu Granule Sales Market Share in Volume by Country (2024-2034)
Table 105. Middle East and Africa Anti-Viral Cold And Flu Granule Sales by Country (2024-2034) & (US$ Million)
Table 106. Middle East and Africa Anti-Viral Cold And Flu Granule Sales Market Share in Value by Country (2024-2034)
Table 107. WELEDA Company Information
Table 108. WELEDA Introduction and Business Overview
Table 109. WELEDA Anti-Viral Cold And Flu Granule Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 110. WELEDA Anti-Viral Cold And Flu Granule Product
Table 111. WELEDA Recent Development
Table 112. Sichuan Everbright Pharmaceutical Company Information
Table 113. Sichuan Everbright Pharmaceutical Introduction and Business Overview
Table 114. Sichuan Everbright Pharmaceutical Anti-Viral Cold And Flu Granule Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 115. Sichuan Everbright Pharmaceutical Anti-Viral Cold And Flu Granule Product
Table 116. Sichuan Everbright Pharmaceutical Recent Development
Table 117. Shandong Wohua Pharmaceutical Company Information
Table 118. Shandong Wohua Pharmaceutical Introduction and Business Overview
Table 119. Shandong Wohua Pharmaceutical Anti-Viral Cold And Flu Granule Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 120. Shandong Wohua Pharmaceutical Anti-Viral Cold And Flu Granule Product
Table 121. Shandong Wohua Pharmaceutical Recent Development
Table 122. Liaoning Xingao Pharmaceutical Company Information
Table 123. Liaoning Xingao Pharmaceutical Introduction and Business Overview
Table 124. Liaoning Xingao Pharmaceutical Anti-Viral Cold And Flu Granule Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 125. Liaoning Xingao Pharmaceutical Anti-Viral Cold And Flu Granule Product
Table 126. Liaoning Xingao Pharmaceutical Recent Development
Table 127. Hubei Longda Medicine Technology Company Information
Table 128. Hubei Longda Medicine Technology Introduction and Business Overview
Table 129. Hubei Longda Medicine Technology Anti-Viral Cold And Flu Granule Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 130. Hubei Longda Medicine Technology Anti-Viral Cold And Flu Granule Product
Table 131. Hubei Longda Medicine Technology Recent Development
Table 132. Guangzhou Huacheng pharmaceutical plant Company Information
Table 133. Guangzhou Huacheng pharmaceutical plant Introduction and Business Overview
Table 134. Guangzhou Huacheng pharmaceutical plant Anti-Viral Cold And Flu Granule Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 135. Guangzhou Huacheng pharmaceutical plant Anti-Viral Cold And Flu Granule Product
Table 136. Guangzhou Huacheng pharmaceutical plant Recent Development
Table 137. Confidence Company Information
Table 138. Confidence Introduction and Business Overview
Table 139. Confidence Anti-Viral Cold And Flu Granule Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 140. Confidence Anti-Viral Cold And Flu Granule Product
Table 141. Confidence Recent Development
Table 142. Zhuhai AIA Pharmaceutical Company Information
Table 143. Zhuhai AIA Pharmaceutical Introduction and Business Overview
Table 144. Zhuhai AIA Pharmaceutical Anti-Viral Cold And Flu Granule Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 145. Zhuhai AIA Pharmaceutical Anti-Viral Cold And Flu Granule Product
Table 146. Zhuhai AIA Pharmaceutical Recent Development
Table 147. Taihua Pharmacy Company Information
Table 148. Taihua Pharmacy Introduction and Business Overview
Table 149. Taihua Pharmacy Anti-Viral Cold And Flu Granule Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 150. Taihua Pharmacy Anti-Viral Cold And Flu Granule Product
Table 151. Taihua Pharmacy Recent Development
Table 152. Jiangsu Jurong Pharmaceutical Company Information
Table 153. Jiangsu Jurong Pharmaceutical Introduction and Business Overview
Table 154. Jiangsu Jurong Pharmaceutical Anti-Viral Cold And Flu Granule Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 155. Jiangsu Jurong Pharmaceutical Anti-Viral Cold And Flu Granule Product
Table 156. Jiangsu Jurong Pharmaceutical Recent Development
Table 157. Jiangsu Kanion Pharmaceutical Company Information
Table 158. Jiangsu Kanion Pharmaceutical Introduction and Business Overview
Table 159. Jiangsu Kanion Pharmaceutical Anti-Viral Cold And Flu Granule Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 160. Jiangsu Kanion Pharmaceutical Anti-Viral Cold And Flu Granule Product
Table 161. Jiangsu Kanion Pharmaceutical Recent Development
Table 162. Laotongjun Pharmaceutical Company Information
Table 163. Laotongjun Pharmaceutical Introduction and Business Overview
Table 164. Laotongjun Pharmaceutical Anti-Viral Cold And Flu Granule Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 165. Laotongjun Pharmaceutical Anti-Viral Cold And Flu Granule Product
Table 166. Laotongjun Pharmaceutical Recent Development
Table 167. Wuhan Jinpu Pharmaceutical Company Information
Table 168. Wuhan Jinpu Pharmaceutical Introduction and Business Overview
Table 169. Wuhan Jinpu Pharmaceutical Anti-Viral Cold And Flu Granule Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 170. Wuhan Jinpu Pharmaceutical Anti-Viral Cold And Flu Granule Product
Table 171. Wuhan Jinpu Pharmaceutical Recent Development
Table 172. Jiangsu Xinxian Pharmaceutical Company Information
Table 173. Jiangsu Xinxian Pharmaceutical Introduction and Business Overview
Table 174. Jiangsu Xinxian Pharmaceutical Anti-Viral Cold And Flu Granule Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 175. Jiangsu Xinxian Pharmaceutical Anti-Viral Cold And Flu Granule Product
Table 176. Jiangsu Xinxian Pharmaceutical Recent Development
Table 177. Quetzal Company Information
Table 178. Quetzal Introduction and Business Overview
Table 179. Quetzal Anti-Viral Cold And Flu Granule Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 180. Quetzal Anti-Viral Cold And Flu Granule Product
Table 181. Quetzal Recent Development
Table 182. Kangxin Pharmaceutical Company Information
Table 183. Kangxin Pharmaceutical Introduction and Business Overview
Table 184. Kangxin Pharmaceutical Anti-Viral Cold And Flu Granule Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 185. Kangxin Pharmaceutical Anti-Viral Cold And Flu Granule Product
Table 186. Kangxin Pharmaceutical Recent Development
Table 187. SHANXI TAIHANG PHARMACEUTICAL Company Information
Table 188. SHANXI TAIHANG PHARMACEUTICAL Introduction and Business Overview
Table 189. SHANXI TAIHANG PHARMACEUTICAL Anti-Viral Cold And Flu Granule Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 190. SHANXI TAIHANG PHARMACEUTICAL Anti-Viral Cold And Flu Granule Product
Table 191. SHANXI TAIHANG PHARMACEUTICAL Recent Development
Table 192. Henan Tongyuan Pharmaceutical Company Information
Table 193. Henan Tongyuan Pharmaceutical Introduction and Business Overview
Table 194. Henan Tongyuan Pharmaceutical Anti-Viral Cold And Flu Granule Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 195. Henan Tongyuan Pharmaceutical Anti-Viral Cold And Flu Granule Product
Table 196. Henan Tongyuan Pharmaceutical Recent Development
Table 197. BAIHUI PHARMA Company Information
Table 198. BAIHUI PHARMA Introduction and Business Overview
Table 199. BAIHUI PHARMA Anti-Viral Cold And Flu Granule Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 200. BAIHUI PHARMA Anti-Viral Cold And Flu Granule Product
Table 201. BAIHUI PHARMA Recent Development
Table 202. Xiangxue Pharmaceutical Company Information
Table 203. Xiangxue Pharmaceutical Introduction and Business Overview
Table 204. Xiangxue Pharmaceutical Anti-Viral Cold And Flu Granule Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 205. Xiangxue Pharmaceutical Anti-Viral Cold And Flu Granule Product
Table 206. Xiangxue Pharmaceutical Recent Development
Table 207. North Hulunbuir pharmaceutical limited company Company Information
Table 208. North Hulunbuir pharmaceutical limited company Introduction and Business Overview
Table 209. North Hulunbuir pharmaceutical limited company Anti-Viral Cold And Flu Granule Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 210. North Hulunbuir pharmaceutical limited company Anti-Viral Cold And Flu Granule Product
Table 211. North Hulunbuir pharmaceutical limited company Recent Development
Table 212. Key Raw Materials Lists
Table 213. Raw Materials Key Suppliers Lists
Table 214. Anti-Viral Cold And Flu Granule Market Trends
Table 215. Anti-Viral Cold And Flu Granule Market Drivers
Table 216. Anti-Viral Cold And Flu Granule Market Challenges
Table 217. Anti-Viral Cold And Flu Granule Market Restraints
Table 218. Anti-Viral Cold And Flu Granule Distributors List
Table 219. Anti-Viral Cold And Flu Granule Downstream Customers
Table 220. Research Programs/Design for This Report
Table 221. Key Data Information from Secondary Sources
Table 222. Key Data Information from Primary Sources
List of Figures
Figure 1. Anti-Viral Cold And Flu Granule Product Picture
Figure 2. Global Anti-Viral Cold And Flu Granule Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Anti-Viral Cold And Flu Granule Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Anti-Viral Cold And Flu Granule Sales Status and Outlook (2024-2034) & (K Units)
Figure 5. Product Picture of Children's Edition
Figure 6. Global Children's Edition Sales YoY Growth (2024-2034) & (K Units)
Figure 7. Product Picture of Adults' Edition
Figure 8. Global Adults' Edition Sales YoY Growth (2024-2034) & (K Units)
Figure 9. Global Anti-Viral Cold And Flu Granule Sales by Type (2024-2034) & (US$ Million)
Figure 10. Global Anti-Viral Cold And Flu Granule Sales Market Share by Type in 2022 & 2034
Figure 11. North America Anti-Viral Cold And Flu Granule Sales Market Share in Volume by Type in 2022
Figure 12. North America Anti-Viral Cold And Flu Granule Sales Market Share in Value by Type in 2022
Figure 13. Europe Anti-Viral Cold And Flu Granule Sales Market Share in Volume by Type in 2022
Figure 14. Europe Anti-Viral Cold And Flu Granule Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Anti-Viral Cold And Flu Granule Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Anti-Viral Cold And Flu Granule Sales Market Share in Value by Type in 2022
Figure 17. Latin America Anti-Viral Cold And Flu Granule Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Anti-Viral Cold And Flu Granule Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Anti-Viral Cold And Flu Granule Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Anti-Viral Cold And Flu Granule Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Anti-Viral Cold And Flu Granule Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Anti-Viral Cold And Flu Granule Revenue in 2022
Figure 23. Anti-Viral Cold And Flu Granule Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 24. Product Picture of Retail Pharmacies
Figure 25. Global Retail Pharmacies Sales YoY Growth (2024-2034) & (K Units)
Figure 26. Product Picture of Hospital
Figure 27. Global Hospital Sales YoY Growth (2024-2034) & (K Units)
Figure 28. Product Picture of Online Sales Platforms
Figure 29. Global Online Sales Platforms Sales YoY Growth (2024-2034) & (K Units)
Figure 30. Global Anti-Viral Cold And Flu Granule Sales by Application (2024-2034) & (US$ Million)
Figure 31. Global Anti-Viral Cold And Flu Granule Sales Market Share by Application in 2022 & 2034
Figure 32. North America Anti-Viral Cold And Flu Granule Sales Market Share in Volume by Application in 2022
Figure 33. North America Anti-Viral Cold And Flu Granule Sales Market Share in Value by Application in 2022
Figure 34. Europe Anti-Viral Cold And Flu Granule Sales Market Share in Volume by Application in 2022
Figure 35. Europe Anti-Viral Cold And Flu Granule Sales Market Share in Value by Application in 2022
Figure 36. Asia-Pacific Anti-Viral Cold And Flu Granule Sales Market Share in Volume by Application in 2022
Figure 37. Asia-Pacific Anti-Viral Cold And Flu Granule Sales Market Share in Value by Application in 2022
Figure 38. Latin America Anti-Viral Cold And Flu Granule Sales Market Share in Volume by Application in 2022
Figure 39. Latin America Anti-Viral Cold And Flu Granule Sales Market Share in Value by Application in 2022
Figure 40. Middle East and Africa Anti-Viral Cold And Flu Granule Sales Market Share in Value by Application in 2022
Figure 41. Key Raw Materials Price
Figure 42. Anti-Viral Cold And Flu Granule Manufacturing Cost Structure
Figure 43. Anti-Viral Cold And Flu Granule Industrial Chain Analysis
Figure 44. Channels of Distribution
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed